Dr Prem Global Healthcare Logo

New drug on trial reduces Hepatitis C virus by 97%

Viropharma Inc announced that the drug, it is developing with Wyeth Inc., successfully reduces the hepatitis C virus. It shows during the fourteen-day experimental trial that it cuts the virus by ninety-seven percent.

The drug blocks polymeras, an enzyme which the hepatitis C virus needs to reproduce itself. Another company Vertex Pharmaceuticals Inc. has developed earlier a drug said to reduce the virus by ninety-nine percent.

Read

Recent Articles:

Scroll to Top